×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
Vision
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
Vision
Showcase
Demo
←
Home
/
Wiki
/
Clinical: Lemborexant for AD Biomarkers (NCT06274528)
clinical
886 words
KG: ent-clin-1d22abb0
2026-03-27
kind:clinical-trial
section:clinical-trials
state:published
Contents
Lemborexant for AD Biomarkers (NCT06274528)
Knowledge Graph
Related Hypotheses (12)
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.65
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.57
Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
Aquaporin-4 Polarization Rescue
Score: 0.51
Orexin-Microglia Modulation Therapy
Score: 0.49
Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.48
Circadian-Gated Maresin Biosynthesis Amplification
Score: 0.47
Hypocretin-Neurogenesis Coupling Therapy
Score: 0.45
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39
Show 7 more
Related Analyses (4)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Related Experiments (3)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40